SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors debate the impact of potential upcoming financial disclosures and ongoing legal challenges surrounding the company. The community remains deeply polarized, with active discussions focusing on the stock's future viability, the platform's monetization strategy, and broader political rhetoric.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors monitor an upcoming European Medicines Agency (EMA) committee opinion, with optimism regarding potential EU approval following the recent U.S. FDA clearance. The community is actively discussing the stock's volatility, a recent significant debt buyback, and high short interest, while awaiting updates on commercial performance and potential near-term milestone payments.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending due to heightened volatility driven by intense geopolitical tensions in the Middle East, specifically reports of Iranian ballistic missile activity and ongoing concerns over the stability of the Strait of Hormuz. While some market participants are betting on potential diplomatic breakthroughs and price stabilization, the broader community is actively debating whether current price action reflects genuine supply-demand realities or is the result of government manipulation and strategic reserve management.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is drawing significant attention as investors balance its technology-focused growth potential with its monthly dividend income strategy, often discussing it alongside peer funds like QQQI and JEPI for portfolio stability. Community members remain highly engaged in debates over dividend sustainability, the impact of market volatility on option premiums, and long-term income generation strategies for retirement.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is experiencing significant volatility as the market balances strong fundamental growth and surging global LNG spot prices against recurring geopolitical tensions in the Middle East. While community members highlight the stock's potential as a major U.S. LNG exporter, trading remains heavily influenced by speculative news cycles regarding conflict in the Strait of Hormuz and diplomatic rhetoric.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve is trending as market participants closely monitor the ongoing administrative law judge hearings regarding federal cannabis rescheduling, which many view as a pivotal catalyst for the industry's future. The community is actively debating the stock's long-term potential and current valuation, with investors weighing the impacts of institutional accessibility and shifting regulatory landscapes against recent share price volatility.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

The community is actively debating the volatility of TSLL as the underlying stock faces significant downward pressure and potential merger speculation, leading to intense discussions on whether to accumulate shares during the dip or manage risk against further decay.

Themes ETF Trust - Leverage Shares 2X Short SPCX Daily ETF

Leverage Shares 2x Short SPCX Daily ETF 

Traders are actively using the SSPC 2x short ETF to speculate on SpaceX stock as it navigates post-IPO volatility and upcoming share lockup expirations. The community is sharply divided, with many debating the sustainability of current valuations and actively leveraging these inverse instruments to capitalize on rapid price swings.

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Domestic Operations and International Operations segments. The company was founded on November 13, 2014 and is headquartered in Stamford, CT.

Curaleaf Holdings Inc

Curaleaf is currently in focus as investors weigh the stock's international expansion and Q2 earnings report against the broader sector's ongoing volatility and political uncertainty surrounding federal cannabis reform. The community remains deeply divided, with some highlighting the company's valuation and strategic growth, while others express frustration over recent stock performance and the lack of a clear federal catalyst.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors react to the companys selection for a federal initiative aimed at fast-tracking nuclear power deployment for AI data centers, which has sparked intense debate over the stock's future. While some community members view this as a pivotal validation of the firm's commercialization strategy, others remain deeply skeptical, citing ongoing concerns about executive share sales, missed criticality deadlines, and the company's lack of revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PTC Inc. (PTC) Q3 Earnings and Revenues Miss Estimates

PTC Inc. (PTC) delivered earnings and revenue surprises of -1.25% and -2.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Commvault Systems (CVLT) Beats Q1 Earnings and Revenue Estimates

Commvault (CVLT) delivered earnings and revenue surprises of +20.34% and +0.99%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Pegasystems (PEGA) Lags Q2 Earnings and Revenue Estimates

Pegasystems (PEGA) delivered earnings and revenue surprises of -18.61% and -1.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?

OPRX and DOCS are betting big on AI-driven healthcare engagement as cautious pharma spending pressures near-term growth.

OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?

OPRX's shares slid 30% in a month as MFN pricing and cautious pharma spending hit revenue, even as DAAP growth and EBITDA surged.

OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds

OptimizeRx expands DSP integration to unlock scalable EHR ad campaigns and boost inventory use despite lowering 2026 revenue guidance.

OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?

OPRX cuts 2026 revenue view to $95-$100M as MFN pricing disruption and macro uncertainty squeeze budgets - will pressures ease?

OptimizeRx (OPRX) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates

OptimizeRx (OPRX) delivered earnings and revenue surprises of +1,300.00% and +7.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

OptimizeRx Expands EHR Advertising Reach With New DSP Integration

OPRX launched a programmatic EHR ad connection for DSPs, expanding point-of-care targeting and access to authenticated inventory.


$OPRX Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.03 up 75.00% YoY
• Reported revenue of $19.84M down -9.50% YoY
• OptimizeRx updated its fiscal year 2026 guidance, now expecting revenue of $95M to $100M and adjusted EBITDA of $21M to $25M for the year.

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

OptimizeRx Corp

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

OPRXOptimizeRx Corp

Fundamentals

Connect Stocktwits to ChatGPT

Latest OPRX News